Prednisone to Methylprednisolone Conversion
Use a 1:0.8 conversion ratio: 5 mg prednisone equals 4 mg methylprednisolone. This is the standard equivalency established by FDA labeling and confirmed by clinical guidelines 1.
Conversion Ratio
The FDA drug label explicitly states that 4 mg of methylprednisolone is equivalent to 5 mg of prednisolone (and prednisone and prednisolone are used interchangeably) 1. This means:
- 5 mg prednisone = 4 mg methylprednisolone
- Conversion factor: multiply prednisone dose by 0.8
For example:
- 20 mg prednisone → 16 mg methylprednisolone
- 40 mg prednisone → 32 mg methylprednisolone
- 60 mg prednisone → 48 mg methylprednisolone
Physiologic Dose Equivalents
According to the 2024 European Society of Endocrinology guidelines, physiologic daily doses are 2:
- Prednisone: 4-6 mg daily
- Methylprednisolone: 3-5 mg daily
This confirms the approximate 1:0.8 ratio at physiologic replacement doses.
Dosing Considerations
Timing of Administration
- Administer methylprednisolone in the morning before 9 AM to minimize HPA axis suppression 1, 3
- Maximal adrenal cortical activity occurs between 2 AM and 8 AM; morning dosing aligns with physiologic cortisol rhythm
Pharmacokinetic Advantages
Methylprednisolone has more predictable pharmacokinetics than prednisone 4:
- Linear, dose-proportional kinetics with no dose dependency
- Prednisone shows marked dose-dependent clearance due to saturable protein binding
- Methylprednisolone concentrations are directly proportional to dose, making dosing more predictable
Dose Range
The FDA label indicates methylprednisolone tablets may range from 4 mg to 48 mg daily depending on disease severity 1. Apply the 0.8 conversion factor to the patient's current prednisone dose to determine the appropriate methylprednisolone dose.
Critical Warnings
Gradual Withdrawal Required
Never abruptly discontinue after long-term therapy (>3-4 weeks at supraphysiologic doses) 2, 1. Risk of adrenal crisis exists, with mortality risk highest in the first 2 months after glucocorticoid cessation 2.
Monitoring Requirements
- Constant monitoring needed for dose adjustments based on clinical response 1
- Watch for disease exacerbations, remissions, or stressful situations requiring temporary dose increases
- Consider alternate-day therapy for long-term treatment to minimize HPA suppression 1
Bioavailability Consideration
Research demonstrates that 1250 mg oral prednisone has similar bioavailability to 1000 mg IV methylprednisolone at 24 hours 5, suggesting the oral conversion ratio holds even at higher doses, though this was studied in the context of MS exacerbations specifically.